1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Oncolytic Virus Drug Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Phase 1
1.2.3 Phase 2
1.2.4 Others
1.3 Market by Application
1.3.1 Global Oncolytic Virus Drug Treatment Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Melanoma
1.3.3 Prostate Cancer
1.3.4 Breast Cancer
1.3.5 Ovarian Cancer
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Oncolytic Virus Drug Treatment Market Perspective (2018-2029)
2.2 Oncolytic Virus Drug Treatment Growth Trends by Region
2.2.1 Global Oncolytic Virus Drug Treatment Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Oncolytic Virus Drug Treatment Historic Market Size by Region (2018-2023)
2.2.3 Oncolytic Virus Drug Treatment Forecasted Market Size by Region (2024-2029)
2.3 Oncolytic Virus Drug Treatment Market Dynamics
2.3.1 Oncolytic Virus Drug Treatment Industry Trends
2.3.2 Oncolytic Virus Drug Treatment Market Drivers
2.3.3 Oncolytic Virus Drug Treatment Market Challenges
2.3.4 Oncolytic Virus Drug Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Oncolytic Virus Drug Treatment Players by Revenue
3.1.1 Global Top Oncolytic Virus Drug Treatment Players by Revenue (2018-2023)
3.1.2 Global Oncolytic Virus Drug Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Oncolytic Virus Drug Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Oncolytic Virus Drug Treatment Revenue
3.4 Global Oncolytic Virus Drug Treatment Market Concentration Ratio
3.4.1 Global Oncolytic Virus Drug Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oncolytic Virus Drug Treatment Revenue in 2022
3.5 Oncolytic Virus Drug Treatment Key Players Head office and Area Served
3.6 Key Players Oncolytic Virus Drug Treatment Product Solution and Service
3.7 Date of Enter into Oncolytic Virus Drug Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Oncolytic Virus Drug Treatment Breakdown Data by Type
4.1 Global Oncolytic Virus Drug Treatment Historic Market Size by Type (2018-2023)
4.2 Global Oncolytic Virus Drug Treatment Forecasted Market Size by Type (2024-2029)
5 Oncolytic Virus Drug Treatment Breakdown Data by Application
5.1 Global Oncolytic Virus Drug Treatment Historic Market Size by Application (2018-2023)
5.2 Global Oncolytic Virus Drug Treatment Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Oncolytic Virus Drug Treatment Market Size (2018-2029)
6.2 North America Oncolytic Virus Drug Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Oncolytic Virus Drug Treatment Market Size by Country (2018-2023)
6.4 North America Oncolytic Virus Drug Treatment Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Oncolytic Virus Drug Treatment Market Size (2018-2029)
7.2 Europe Oncolytic Virus Drug Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Oncolytic Virus Drug Treatment Market Size by Country (2018-2023)
7.4 Europe Oncolytic Virus Drug Treatment Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Oncolytic Virus Drug Treatment Market Size (2018-2029)
8.2 Asia-Pacific Oncolytic Virus Drug Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Oncolytic Virus Drug Treatment Market Size by Region (2018-2023)
8.4 Asia-Pacific Oncolytic Virus Drug Treatment Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Oncolytic Virus Drug Treatment Market Size (2018-2029)
9.2 Latin America Oncolytic Virus Drug Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Oncolytic Virus Drug Treatment Market Size by Country (2018-2023)
9.4 Latin America Oncolytic Virus Drug Treatment Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Oncolytic Virus Drug Treatment Market Size (2018-2029)
10.2 Middle East & Africa Oncolytic Virus Drug Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Oncolytic Virus Drug Treatment Market Size by Country (2018-2023)
10.4 Middle East & Africa Oncolytic Virus Drug Treatment Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Amgen
11.1.1 Amgen Company Detail
11.1.2 Amgen Business Overview
11.1.3 Amgen Oncolytic Virus Drug Treatment Introduction
11.1.4 Amgen Revenue in Oncolytic Virus Drug Treatment Business (2018-2023)
11.1.5 Amgen Recent Development
11.2 Oncolytics Biotech
11.2.1 Oncolytics Biotech Company Detail
11.2.2 Oncolytics Biotech Business Overview
11.2.3 Oncolytics Biotech Oncolytic Virus Drug Treatment Introduction
11.2.4 Oncolytics Biotech Revenue in Oncolytic Virus Drug Treatment Business (2018-2023)
11.2.5 Oncolytics Biotech Recent Development
11.3 Viralytics
11.3.1 Viralytics Company Detail
11.3.2 Viralytics Business Overview
11.3.3 Viralytics Oncolytic Virus Drug Treatment Introduction
11.3.4 Viralytics Revenue in Oncolytic Virus Drug Treatment Business (2018-2023)
11.3.5 Viralytics Recent Development
11.4 Transgene SA
11.4.1 Transgene SA Company Detail
11.4.2 Transgene SA Business Overview
11.4.3 Transgene SA Oncolytic Virus Drug Treatment Introduction
11.4.4 Transgene SA Revenue in Oncolytic Virus Drug Treatment Business (2018-2023)
11.4.5 Transgene SA Recent Development
11.5 Oncolys BioPharma
11.5.1 Oncolys BioPharma Company Detail
11.5.2 Oncolys BioPharma Business Overview
11.5.3 Oncolys BioPharma Oncolytic Virus Drug Treatment Introduction
11.5.4 Oncolys BioPharma Revenue in Oncolytic Virus Drug Treatment Business (2018-2023)
11.5.5 Oncolys BioPharma Recent Development
11.6 Targovax
11.6.1 Targovax Company Detail
11.6.2 Targovax Business Overview
11.6.3 Targovax Oncolytic Virus Drug Treatment Introduction
11.6.4 Targovax Revenue in Oncolytic Virus Drug Treatment Business (2018-2023)
11.6.5 Targovax Recent Development
11.7 PsiOxus Therapeutics
11.7.1 PsiOxus Therapeutics Company Detail
11.7.2 PsiOxus Therapeutics Business Overview
11.7.3 PsiOxus Therapeutics Oncolytic Virus Drug Treatment Introduction
11.7.4 PsiOxus Therapeutics Revenue in Oncolytic Virus Drug Treatment Business (2018-2023)
11.7.5 PsiOxus Therapeutics Recent Development
11.8 SillaJen Biotherapeutics
11.8.1 SillaJen Biotherapeutics Company Detail
11.8.2 SillaJen Biotherapeutics Business Overview
11.8.3 SillaJen Biotherapeutics Oncolytic Virus Drug Treatment Introduction
11.8.4 SillaJen Biotherapeutics Revenue in Oncolytic Virus Drug Treatment Business (2018-2023)
11.8.5 SillaJen Biotherapeutics Recent Development
11.9 Sorrento Therapeutics
11.9.1 Sorrento Therapeutics Company Detail
11.9.2 Sorrento Therapeutics Business Overview
11.9.3 Sorrento Therapeutics Oncolytic Virus Drug Treatment Introduction
11.9.4 Sorrento Therapeutics Revenue in Oncolytic Virus Drug Treatment Business (2018-2023)
11.9.5 Sorrento Therapeutics Recent Development
11.10 Lokon Pharma
11.10.1 Lokon Pharma Company Detail
11.10.2 Lokon Pharma Business Overview
11.10.3 Lokon Pharma Oncolytic Virus Drug Treatment Introduction
11.10.4 Lokon Pharma Revenue in Oncolytic Virus Drug Treatment Business (2018-2023)
11.10.5 Lokon Pharma Recent Development
11.11 Genelux Corporation
11.11.1 Genelux Corporation Company Detail
11.11.2 Genelux Corporation Business Overview
11.11.3 Genelux Corporation Oncolytic Virus Drug Treatment Introduction
11.11.4 Genelux Corporation Revenue in Oncolytic Virus Drug Treatment Business (2018-2023)
11.11.5 Genelux Corporation Recent Development
11.12 Vyriad
11.12.1 Vyriad Company Detail
11.12.2 Vyriad Business Overview
11.12.3 Vyriad Oncolytic Virus Drug Treatment Introduction
11.12.4 Vyriad Revenue in Oncolytic Virus Drug Treatment Business (2018-2023)
11.12.5 Vyriad Recent Development
11.13 TILT Biotherapeutics
11.13.1 TILT Biotherapeutics Company Detail
11.13.2 TILT Biotherapeutics Business Overview
11.13.3 TILT Biotherapeutics Oncolytic Virus Drug Treatment Introduction
11.13.4 TILT Biotherapeutics Revenue in Oncolytic Virus Drug Treatment Business (2018-2023)
11.13.5 TILT Biotherapeutics Recent Development
11.14 Cold Genesys
11.14.1 Cold Genesys Company Detail
11.14.2 Cold Genesys Business Overview
11.14.3 Cold Genesys Oncolytic Virus Drug Treatment Introduction
11.14.4 Cold Genesys Revenue in Oncolytic Virus Drug Treatment Business (2018-2023)
11.14.5 Cold Genesys Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
